488 related articles for article (PubMed ID: 36275622)
1. CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders.
Baier A; Szyszka R
Front Mol Biosci; 2022; 9():916063. PubMed ID: 36275622
[TBL] [Abstract][Full Text] [Related]
2. Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases.
Perez DI; Gil C; Martinez A
Med Res Rev; 2011 Nov; 31(6):924-54. PubMed ID: 20577972
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. Evidence that phosphorylated residues are not strictly required for efficient targeting by casein kinase-1.
Marin O; Meggio F; Sarno S; Andretta M; Pinna LA
Eur J Biochem; 1994 Jul; 223(2):647-53. PubMed ID: 8055935
[TBL] [Abstract][Full Text] [Related]
4. Casein kinases as potential therapeutic targets.
Cozza G; Pinna LA
Expert Opin Ther Targets; 2016; 20(3):319-40. PubMed ID: 26565594
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the proteins of the extracellular matrix of mineralized tissues by casein kinase-like activity.
Veis A; Sfeir C; Wu CB
Crit Rev Oral Biol Med; 1997; 8(4):360-79. PubMed ID: 9391750
[TBL] [Abstract][Full Text] [Related]
6. Rat liver Golgi apparatus contains a protein kinase similar to the casein kinase of lactating mammary gland.
Lasa M; Marin O; Pinna LA
Eur J Biochem; 1997 Feb; 243(3):719-25. PubMed ID: 9057837
[TBL] [Abstract][Full Text] [Related]
7. T. cruzi DNA polymerase beta (Tcpolβ) is phosphorylated in vitro by CK1, CK2 and TcAUK1 leading to the potentiation of its DNA synthesis activity.
Maldonado E; Rojas DA; Urbina F; Solari A
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009588. PubMed ID: 34260580
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Development of Casein Kinase 1 Inhibitors.
Li SS; Dong YH; Liu ZP
Curr Med Chem; 2021; 28(8):1585-1604. PubMed ID: 32660395
[TBL] [Abstract][Full Text] [Related]
9. Identification of casein kinase 1, casein kinase 2, and cAMP-dependent protein kinase-like activities in Trypanosoma evansi.
Galán-Caridad JM; Calabokis M; Uzcanga G; Aponte F; Bubis J
Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):845-54. PubMed ID: 15761601
[TBL] [Abstract][Full Text] [Related]
10. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
[TBL] [Abstract][Full Text] [Related]
11. Tau Tubulin Kinase 1 (TTBK1), a new player in the fight against neurodegenerative diseases.
Nozal V; Martinez A
Eur J Med Chem; 2019 Jan; 161():39-47. PubMed ID: 30342424
[TBL] [Abstract][Full Text] [Related]
12. CK2-An Emerging Target for Neurological and Psychiatric Disorders.
Castello J; Ragnauth A; Friedman E; Rebholz H
Pharmaceuticals (Basel); 2017 Jan; 10(1):. PubMed ID: 28067771
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.
Stavenuiter F; Gale AJ; Heeb MJ
FASEB J; 2013 Jul; 27(7):2918-25. PubMed ID: 23580615
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of two new peptide substrates for the specific and sensitive monitoring of casein kinases-1 and -2.
Marin O; Meggio F; Pinna LA
Biochem Biophys Res Commun; 1994 Feb; 198(3):898-905. PubMed ID: 8117294
[TBL] [Abstract][Full Text] [Related]
15. Golgi apparatus mammary gland casein kinase: monitoring by a specific peptide substrate and definition of specificity determinants.
Lasa-Benito M; Marin O; Meggio F; Pinna LA
FEBS Lett; 1996 Mar; 382(1-2):149-52. PubMed ID: 8612738
[TBL] [Abstract][Full Text] [Related]
16. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes.
Knippschild U; Gocht A; Wolff S; Huber N; Löhler J; Stöter M
Cell Signal; 2005 Jun; 17(6):675-89. PubMed ID: 15722192
[TBL] [Abstract][Full Text] [Related]
17. Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.
Gyenis L; Duncan JS; Turowec JP; Bretner M; Litchfield DW
J Proteome Res; 2011 Nov; 10(11):4887-901. PubMed ID: 21936567
[TBL] [Abstract][Full Text] [Related]
18. CK2 Regulation: Perspectives in 2021.
Roffey SE; Litchfield DW
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680478
[TBL] [Abstract][Full Text] [Related]
19. The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development.
Knippschild U; Wolff S; Giamas G; Brockschmidt C; Wittau M; Würl PU; Eismann T; Stöter M
Onkologie; 2005 Oct; 28(10):508-14. PubMed ID: 16186692
[TBL] [Abstract][Full Text] [Related]
20. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders.
Benek O; Hroch L; Aitken L; Gunn-Moore F; Vinklarova L; Kuca K; Perez DI; Perez C; Martinez A; Fisar Z; Musilek K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):665-670. PubMed ID: 29536773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
